Acetylcysteine (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Acetylcysteine drug offered from Fresenius Kabi USA, LLC. This Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | Acetylcysteine |
| SUBSTANCE NAME: | ACETYLCYSTEINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-11-09 |
| END MARKETING DATE: | 0000-00-00 |
Acetylcysteine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Acetylcysteine from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/mL) |
| START MARKETING DATE: | 2012-11-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-963_0c13eb89-0cad-7352-e054-00144ff88e88 |
| PRODUCT NDC: | 63323-963 |
| APPLICATION NUMBER: | ANDA200644 |
Other ACETYLCYSTEINE Pharmaceutical Manufacturers / Labelers:
